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The choroid plexuses (CPs) are highly vascularized branched structures that protrude into the ventricles
of the brain, and form a unique interface between the blood and the cerebrospinal fluid (CSF). In recent
years, novel functions have been attributed to this tissue such as in immune and chemical surveillance of
the central nervous system, brain development, adult neurogenesis and circadian rhythm regulation. Sex
hormones (SH) are widely recognized as modulators in several neurodegenerative diseases, and there is
evidence that estrogens and androgens regulate several fundamental biological functions in the CPs.
Therefore, SH are likely to affect the composition of the CSF impacting on brain homeostasis. This review
will look at implications of the CPs’ sex-related specificities.
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cerebrospinal fluid).1. Introduction
The choroid plexuses (CPs) are highly vascularized structures,
located in the ventricular system of the brain (Fig. 1). In the lateral
ventricles of the mammalian brain, CPs form a sheet-like structure,
whereas in the third and fourth ventricles these resemble villus-
like structures. The CPs are formed by single layers of cuboidal
epithelial cells laying on a basement membrane. Bellow the base-
ment membrane, within the connective tissue, lays a network of
fenestrated capillaries, fibroblasts and immune cells (e.g., mast
cells, macrophages, granulocytes), and a rich extracellular matrix
(Redzic and Segal, 2004). The CPs’ epithelial cells (CPEC) are con-
nected by tight junctions, adherens junctions and desmosomes,
forming a sealed barrier that prevents paracellular movement of
substances into and out of the brain.
CPEC also have numerous microvilli and cilia at the ventricle
facing (apical) side, and extensive infolding at the blood facing
(basolateral) side, thus providing a large surface for contact
between the epithelium and the CSF and between the epithelium
and the stroma interstitial fluid on the other side (Ghersi-Egea
et al., 2009). In addition, the CPEC apical and basolateral mem-
branes contain a wide range of transporters, channels, pumps
and receptors that mediate and set the pace for the exchange of
compounds between the periphery and the CSF. These are essential
to fulfil the CPs’ role as a source of nutrients for the brain, and also
for the excretion of molecules originating from the brain
metabolism.
Several fundamental functions have been attributed to the CPs
and have been within the scope of recent reviews. The best known
functions of CPs are CSF formation (Damkier et al., 2013), nutrient
and hormone supply to the CSF and brain, clearance of deleterious
compounds and waste products from brain metabolism (Johanson
et al., 2011; Richardson et al., 2015; Spector et al., 2015), immune
surveillance (Schwartz and Baruch, 2014), amyloid clearance
(Pahnke et al., 2014; Pascale et al., 2011), and neurogenesis
(Falcao et al., 2012; Johansson, 2014; Lun et al., 2015). Other
emerging functions of the CPs are chemical surveillance as
depicted from the presence of the taste and olfactory transductionable 1
ex hormone receptors expressed in the choroid plexuses.pathways in CPEC (Gonçalves et al., 2016; Tomás et al., 2016) and
the potential function of the CP as an extra-suprachiasmatic
nucleus circadian clock (Quintela et al., 2015b).2. Search strategy, publication selection criteria and data
analysis
Research articles were selected from PubMed database from
until October 2016 on the basis of the quality of the evidence they
provide following the criteria established by the Grading of Recom-
mendations Assessment, Development and Evaluating (GRADE)
working group (www.gradeworkinggroup.org). Search terms used
were: brain barriers, immune surveillance, chemical surveillance,
sex hormones, sex differences, estrogen, androgen, progesterone,
Table 2
Comparison of the number of up- and down-regulated genes in rat choroid plexuses
after gonadectomy and between sham males and females.
Fold-
change
Females OVX vs
sham
Males OOX vs sham Males sham vs
females sham
No. of genes (% of
genome)
No. of genes (% of
genome)
No. of genes (% of
genome)
Up-regulated
>1.5 1168 (4.7%) 426 (1.7%) 453 (1.8%)
Down-regulated
>1.5 1328 (5.3%) 123 (0.5%) 160 (0.6%)
OOX – orchidectomized male rats; OVX – ovariectomized female rats.
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nalling, neurogenesis, cerebrospinal fluid, and detoxification.
Gene expression data presented in the tables provided (Tables 1
and 4–11) were retrieved from a cDNA microarray to compare the
gene expression profiling of CPs’ samples from sham-operated
male and female Wistar rats (2 months ± 2 weeks) and male and
female gonadectomised animals. Two weeks after surgery, sham-
operated and castrated animals were sacrificed and their CPs were
dissected from both lateral ventricles. Sampling of CPs included the
connective tissue underneath. Hormonal changes were confirmed
by comparing serum estradiol and testosterone levels (Quintela
et al., 2013, 2016). cDNA microarray data retrieved from this study
have been deposited in NCBIs Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo/, accession number GSE87045).
The most relevant genes associated with each CPs’ functions are
presented, and their expression levels compared between males
and females either sham-operated or gonadectomised. Fold change
(mRNA expression ratio of male CPs versus female CPs or gonadec-
tomised vs sham) is presented, using a P-value cut-off of 0.05.
These microarray data have been validated, by real-time reverse
transcriptase-polymerase chain reaction, for 21 selected genes, to
compare expression between sham males and sham females and
to gonadectomised animals. In addition, simple gene expression
has been confirmed for another 20 transcripts (Gonçalves et al.,
2016; Quintela et al., 2013, 2016; Quintela et al., 2015a; Tomás
et al., 2016).
The following sections review the available literature on the
multiple functions of the CPs taking into consideration the high
susceptibility of the CPs to sex hormone (SH) actions. Particular
focus is given to data retrieved from this cDNA microarray study
highlighting sex differences and their potential implications in dis-
eases of the central nervous system (CNS).3. The choroid plexus as a sex hormone target
There is an overall acceptance that SH are essential modulators
of the CNS. Several brain pathologies present sex differences
regarding their prevalence, symptoms and prognosis, such as
Parkinson’s disease (Gillies et al., 2014), Alzheimer’s disease (Li
and Singh, 2014), multiple sclerosis, depression and stroke
(Hanamsagar and Bilbo, 2016). Both hormonal steroids released
by peripheral steroidogenic glands and tissues, and steroids syn-
thesized by neurons and glial cells (Baulieu, 1998) may contribute
for these sex differences (Cosimo Melcangi and Garcia-Segura,
2010). The CPs are relevant multifunctional SH targets, containing
sex hormone receptors, such as progesterone receptor (Quadros
et al., 2007), alpha and beta estrogen receptor (ER) (Hong-Goka
and Chang, 2004) and androgen receptor (AR) (Alves et al., 2009).
Their presence features the regulation of the CPs’ transcriptome
and secretome by SH. Of notice, there are no studies on whether
these may underlie many of the sex-related differences seen in
neurological and neurodegenerative diseases where the CPs may
be involved as recently reviewed (Marques et al., 2016).3.1. Progesterone receptors in the CPs
Progesterone improves the outcomes in animal models of trau-
matic brain injury, ischemia, spinal cord injury, peripheral nerve
injury, demyelinating disease, neuromuscular disorders, and sei-
zures through edema reduction, enhancement of neuronal survival,
and regulation of inflammation and apoptosis (Deutsch et al.,
2013). These neuroprotective and neuroregenerative effects are
mediated by their cognate nuclear progesterone receptor (PR) or
membrane bound receptors which are expressed throughout the
brain (Brinton et al., 2008). Data regarding the effects of proges-terone in CPs’ gene expression or about PR expression in the CPs
are still scarce. One of the genes, up-regulated in response to pro-
gesterone is that encoding for transthyretin, a major thyroid hor-
mone and vitamin-carrier protein synthesized and secreted from
the CPs into the CSF (Palha, 2002), both in vivo and in vitro
(Quintela et al., 2011). Nuclear progesterone receptor has been
found in the CPs (Table 1) and a membrane bound progesterone
receptor (Quadros et al., 2007) is present in adult CPs and other
brain regions associated with osmoregulation, suggesting a role
for progesterone in the maintenance of water and ion homeostasis
(Meffre et al., 2005, 2013).3.2. Estrogen receptors in the CPs
Estrogens are relevant modulators of brain functions and path-
ways that drive reproductive behavior and cognition (Bridges,
2015; Engler-Chiurazzi et al., 2016). Despite the overall contro-
versy around their benefits against aging and age-related neurode-
generation, several lines of evidence indicate that estrogens can be
neuroprotective against stroke, traumatic brain injury and neu-
rodegenerative diseases, such as Alzheimer’s and Parkinson’s.
Estrogen actions are mediated by nuclear or membrane-bound
ER, which are also expressed in the CPs. The exact contribution
of the CPs to estrogen-mediated neuroprotection remains elusive,
but this review will provide evidence that estrogens regulate sev-
eral genes encoding key proteins related to neuroprotection. We
have analyzed the expression of nuclear ER alpha and beta in the
CPs. In rat CPEC primary cell cultures and in the Z310 cell line,
ER beta seems to be more abundant than ER alpha, what is corrob-
orated by data from the rat CPs’ transcriptome (Table 1). Of notice,
the CPs of ovariectomized female mice display identical levels of
the two ER receptors, and supplementation with estradiol solely
increases the expression of the ER beta (Quintela et al., 2009).
Interestingly, the CPs from gonadectomized male rats showed
increased expression of ER beta, suggesting that androgens may
reduce ER beta in the CPs (Table 1).3.3. Androgen receptors in the CPs
The AR is also present in the CPs of both male and female
rodents. 5a-dihydrotestosterone (DHT) down-regulates AR expres-
sion in the CPs of gonadectomized male and female mice (Alves
et al., 2009).
Therefore, different hormonal levels, as seen between males
and females and SH decline along aging are likely to set variations
in CPs’ gene and protein expression, including the expression of
their cognate receptors, which is likely to affect CPs’ functions by
eliciting distinctive downstream responses in genes involved in
CPs’ physiology.
Table 3
Hormonal composition of the cerebrospinal fluid.
Compound Female Male Reference
Prolactin (mg/mL) 3.99 ± 1.01 3.26 ± 0.57 Markianos
et al. (2010)
Leptin (pg/mL) 50 ± 11 185 ± 28 Page-Wilson
et al. (2015)
Orexin A (pg/mL) 90.62 ± 15.61 85.91 ± 14.53 Schmidt et al.
(2013)
Melanin-concentrating
hormone (pg/mL)
81.46 ± 12.07 87.19 ± 10.85 Schmidt et al.
(2013)
Oxytocin (pg/mL) 4.3 ± 3 3.3 ± 3 Altemus et al.
(1999)
Pregnenolone (pg/lL) 0.8 ± 0.05 Datta et al.
(1986),
Melcangi et al.
(2013), Molnár
and Kassai-
Bazsa (1997)
Progesterone (pg/lL) 0.39 ± 0.01 0.16 ± 0.002
Tetrahydroprogesterone
(pg/lL)
0.48 ± 0.08
Isopregnonalone (pg/lL) 0.51 ± 0.16
Dehydroepiandrosterone
(pg/lL)
0.15 ± 0.01
Testosterone (pg/lL) 0.065 ± 0.1048 0.08 ± 0.007
Dihydrotestosterone (pg/
lL)
0.76 ± 0.18
3a-Diol = 5a-androstane-
3a (pg/lL)
0.34 ± 0.005
17a-Estradiol (pg/mL) 9.4 ± 10.2
106 C.R.A. Santos et al. / Frontiers in Neuroendocrinology 44 (2017) 103–1213.4. Effects of gonadectomy and sex-related differences in the CPs’
transcriptome
The influence of sex hormones in the CPs’ functions may be
viewed from two perspectives. That strictly originating from the
sex differences when comparing males and females, and that
resulting from gonadectomized female and male rats, compared
with the corresponding sham-operated counterparts.
Comparison of the CPs’ transcriptome of male and female sexu-
ally mature rats (Quintela et al., 2016) revealed 453 up-regulated
(1.8%) and 160 down-regulated (0.6%) genes in male’s CPs. Consid-
ering a minimum of 2.0-fold difference in expression, four down-
regulated pathways were identified (embryonic stem cell differen-
tiation, the visual cycle/retinoate biosynthesis, sharing the same
genes, HIPPO signalling and L-carnitine biosynthesis), whereas
the only pathway differently up-regulated was that of circadian
rhythm signalling. In accordance, the ten most differently
expressed genes between males and females are related to neuro-
genesis and stem cell differentiation (frizzled-related protein 2,
chemokine CC beta receptor 1, insulin growth factor 2 binding pro-
tein 1), neuroprotection (GDNF receptor alpha 1; dopamine beta-
hydroxylase), circadian rhythm (period 2 and 3, chip-derived
repressor of network oscillator) and barrier function (claudin 7)
(Quintela et al., 2016).
The comparison of the CPs’ transcriptome of gonadectomized
male and female rats to sham controls by cDNA microarrays
(Quintela et al., 2013) brought forward overwhelming differences.
Approximately 6000 genes corresponding to 25% of the whole rat
transcriptome were differently expressed between ovariectomized
female rats (OVX) and sham females among which, 1168 (4.7%) ofFig. 2. Main biological functions of the choroid plexuses (CP – choroid plexuses; CSF – c
adherens junction; ZO – zonula occludens protein; JAM – junctional adhesion mole
glucuronosyltransferase).the genes were up-regulated and 1328 (5.3%) genes were
down-regulated, considering fold differences above 1.5 (Table 2).
Gonadectomy did not induce so profound differences in the tran-
scriptome of males’ CPs compared to sham animals, but still 15%
(549 genes) of the rat CPs’ transcriptome experienced variations
corresponding to 426 (1.7%) up-regulated genes, and 123 (0.5%)erebrospinal fluid; CPEC – choroid plexuses epithelial cell; TJ – tight junction; AJ –
cules; Cyp450 – cytochrome P450; GPX – glutathione peroxidase; UGT – UDP
Table 4
Genes expressed in the choroid plexuses associated with cerebrospinal fluid production and osmoregulation.
Gene 
symbol Gene name 
Female 
sham 
OVX vs 
Sham 
Male 
sham 
OOX vs 
Sham 
Male vs 
Female 
Pumps and channels
Agt Angiotensin 
Ace Angiotensin I converting enzyme 1 
Ace2 Angiotensin I converting enzyme 2 
Agtr1a Angiotensin II receptor, type 1a 
Aqp1 Aquaporin 1 
Aqp4 Aquaporin 4 
Aqp5 Aquaporin 5 
Aqp7 Aquaporin 7 
Aqp9 Aquaporin 9 
Avp Arginine vasopressin 
Avpr1b Arginine vasopressin receptor 1B 
Calb1 Calbindin 1 
Calb2 Calbindin 2 
Cl- channels 
Clcn1 Chloride channel 1 
Clcn2 Chloride channel 2 
ClcnKb Chloride channel Kb 
k+ channels 
Kcnk16 Potassium channel, subfamily K, member 16 
Kcnk18 Potassium channel, subfamily K, member 18 
Na+/Ca2+ exchangers 
Slc8a2 Solute carrier family 8 (Na+/Ca2+ exchanger), member 2 
Na+/H+ Exchangers 
Slc9a8 Solute carrier family 9 (Na+/H+ exchanger), member 8 
Na+k+ ATPase 
Atp1a2 ATPase, Na+/K+ transporting, alpha 2 polypeptide 
Anion transporters
Slc26a10 Solute carrier family 26, member 10 
Peptides 
Aldoc Aldolase C, fructose-bisphosphate 
Apoa1 Apolipoprotein A-I 
Apoe Apolipoprotein E 
B2m Beta-2 microglobulin 
C3 Complement C3 
Col1a1 Collagen, type I, alpha 1 
Col10a1 Collagen, type X, alpha 1 
Cst3 Cystatin C 
Ctsd Cathepsin D 
Hcrt Orexin A 
Oxt Oxytocin 
Timp1 TIMP metallopeptidase inhibitor 1 
Ttr Transthyretin 
OOX – orchidectyomized male rats; OVX – ovariectomized female rats 
Basal expression Fold change up-regulation Fold change down-regulation 
>12 >1,5 >1,5 
>8 >2 >2 
>4  >3 >3 
<3,99 
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ing fold differences above 1.5; Table 2). The top five pathways
differently affected by the SH background were olfactory and
taste transduction, metabolism of xenobiotics by cytochrome
P450, pentose and glucuronate interconversions, ascorbate and
aldarate metabolism, steroid hormone biosynthesis and circadian
rhythm.These data suggest that establishment of circadian rhythms and
synthesis of peptides implicated in neurogenesis and neuronal sur-
vival may be seminal functions of the CPs that remarkably differ
betweenmales and females and are affected by the SH background.
Other functions as protein synthesis and trafficking, metabolism
and barrier function seem also to be differently driven by SH
differences (Quintela et al., 2016) as discussed below.
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The following sections provide an overview of possible func-
tional implications of the observed sex differences in the CPs’
transcriptome.
4.1. Production and composition of CSF
A major function of the CPs is CSF formation (Fig. 2), which reg-
ulates homeostasis in the CNS, providing physical protection and
buoyancy for the brain and spinal cord, regulation of intracranial
pressure, waste removal and a supportive environment (Damkier
et al., 2013).
The CPs produce about 80% of the CSF, while the remaining 20%
comes from the interstitial fluid of the brain for which there is a
considerable contribution of the blood-brain-barrier. The rate of
CSF formation in humans is 500–600 mL in 24 h and the total
CSF volume is 90–150 mL in adults meaning that it is replaced
three to four times a day (Damkier et al., 2013). Several differences
between the CSF of males and females have been reported, from
CSF flow dynamics and density (Schiffer et al., 1999; Schmid
Daners et al., 2012) to its actual composition (Table 3).
The CSF formation at the CPs encompasses the passive filtration
of fluid across the highly permeable capillary endothelium that
irrigates the CPs’ stroma and a regulated secretion across the
single-layered CPs’ epithelia sealed by tight junctions at the apical
cell membranes. Water transport across the CPs’ epithelia is con-
trolled by membrane transporters within the epithelium and water
channels like aquaporin 1 and ion transporters at the apical mem-
brane (K+/Cl cotransporter and Na+/K+-ATPase) (Brinker et al.,
2014). There are no major sex-differences or effect of gonadectomy
on the expression of the major CPs’ aquaporins 1 and 4. Despite an
overall expression in several tissues of the body, neither aquapor-Table 5
Genes expressed in the choroid plexuses associated with its barrier function.
Gene 
symbol Gene name 
F
s
Cdh1 Cadherin 1 
Cdh22 Cadherin 22 
Ctnna2 Catenin alpha 2 
Ctnnd2 Catenin delta 2 
Cldn1 Claudin 1  
Cldn2 Claudin 2 
Cldn3 Claudin 3 
Cldn5 Claudin 5 
Cldn6 Claudin 6 
Cldn7 Claudin 7 
Cldn9 Claudin 9 
Cldn11 Claudin 11 
Cldn12 Claudin 12 
Cldn19 Claudin 19 
Cldn22 Claudin 22 
Ocln Occludin 
ZO-1 Zonula occludens 1 
OOX – orchidectyomized male rats; OVX – ovariectomized female rats 
Basal expression Fold change up-regulation 
>12 >1,5 
>8 >2 
>4  >3 
<3,99 ins 5 and 9 have been described in the brain or CPs before (Direito
et al., 2016), but we detected both by cDNA microarrays. Aquapor-
ins 7 and 9 are described to contribute to water, glycerol and urea
diffusion (Badaut, 2010). Interestingly, aquaporins 5 and 7 gene
expression were increased in OVX animals (Table 4).
The driving force for fluid secretion across CPEC is the osmotic
gradient created by the active flux of ions from across the epithelial
layer, which is accompanied by the movement of water. The move-
ment of ions is mediated by transporters and ion channels, which
are asymmetrically distributed between the apical and basolateral
membranes (Redzic and Segal, 2004). Chloride, potassium and
sodium channels also seem to be sensitive to SH in the CPs. We
found increased expression levels of the gene encoding for chloride
channels 1, 2 and KB in OVX compared to sham animals. Dysfunc-
tion of chloride channel 1 gene has been associated with epilepsy
and Huntington’s disease (Imbrici et al., 2015). Solute carrier fam-
ily 9, member 8, a Na+/H+ exchanger, increased in males’ CPs in
comparison to females’ and the solute carrier family 26, member
10 increased upon OVX (Table 4). Differences in the expression of
the Na+/H+ exchangers between males and females have also been
reported in mice renal brush-border membranes where the
exchange rates are higher in males than in females. Castration of
male mice led to a decrease in Na+/H+ exchange to values found
in females (Mackovic´ et al., 1986).
Many of the pivotal hormones, receptors and enzymes, that reg-
ulate systemic water and electrolyte homeostasis, such as aldos-
terone, angiotensin, and arginine vasopressin, are also expressed
in the CPs and differently regulated according to the SH back-
ground, as angiotensin II receptor type 1a and angiotensin convert-
ing enzyme 2, both reduced upon OVX (Table 4).
Other important feature of the CSF is its composition in organic
compounds like vitamins (e.g., ascorbic acid, methyltetrahydro-
falate), hormones and proteins (Merched et al., 1998; Serot et al.,emale 
ham 
OVX vs 
Sham 
Male 
sham 
OOX vs 
Sham 
Male vs 
Female 
Fold change down-regulation 
>1,5 
>2 
>3 
Table 6
Genes expressed in the choroid plexus associated with immune surveillance.
Gene 
symbol Gene name 
Female 
sham 
OVX vs 
Sham 
Male 
sham 
OOX vs 
Sham 
Male vs 
Female 
Chemokines
Ccl1 Chemokine (C-C motif) ligand 1 
Ccl2 Chemokine (C-C motif) ligand 2 
Ccl3 Chemokine (C-C motif) ligand 3 
Ccl7 Chemokine (C-C motif) ligand 7 
Ccl20 chemokine (C-C motif) ligand 20 
Ccr1 chemokine (C-C motif) receptor 1 
Cxcl1 Chemokine (C-X-C motif) ligand 1 
Cxcl3 Chemokine (C-X-C motif) ligand 3 
Xcl1 Chemokine (C motif) ligand 1 
Adhesion molecules 
Glycam1 Glycosylation dependent cell adhesion molecule 1 
Citokines 
Ifna1 Interferon-alpha 1 
OOX – orchidectyomized male rats; OVX – ovariectomized female rats
Basal expression Fold change up-regulation Fold change down-regulation 
>12 >1,5 >1,5 
>8 >2 >2 
>4  >3 >3 
<3,99 
C.R.A. Santos et al. / Frontiers in Neuroendocrinology 44 (2017) 103–121 1092001). The relative contribution of CPs’ cells to the presence of
many of these compounds is still uncertain. Differences in the
CSF composition between sexes have also been assessed in several
frameworks, but there is still a lot to unveil.
Recently, we have compared the most abundant proteins in the
CSF between males and females, and between gonadectomized
male and female rats and sham animals, by 2-D DIGE followed
by LC-MS/MS identification. Only changes in abundance greater
than 1.5 times (up or down) within the 95% confidence level
(p < 0.05) were considered (Quintela et al., 2016). We found that
prostaglandin D2 synthase (1.77-fold), TTR and apolipoprotein A-
I (both with 1.63-fold) and fructose-bisphosphate aldolase C
and insulin like growth factor binding protein 2 (1.52 and
1.43-fold, respectively) are less abundant in the CSF samples
from male than in female rats (Quintela et al., 2016). Interestingly,
gonadectomy in males but not in females induced changes in the
CSF proteome despite the greater differences found in the tran-
scriptome of gonadectomised females compared to sham
(Quintela et al., 2013). In the CSF of orchidectomized male rats
(OOX), transferrin (1.7-fold); TTR (1.63- to 2.14-fold); apolipopro-
tein E (1.72- to 1.96-fold); insulin like growth factor binding pro-
tein 2 (1.65- to 1.96-fold); prostaglandin D2 synthase (1.95- to
2.47-fold) and Apolipoprotein A-I (1.81-fold) were more abundant
than in sham animals, whereas complement C3 (1.49-fold) was
less abundant in the OOX group when compared to sham animals
(Quintela et al., 2016).
Many other peptides previously identified in the supernatant of
CPEC enriched cultures (Thouvenot et al., 2006) are indeed
encoded by genes with high expression in the CPs’ transcriptome
(Table 4), suggesting that they are secreted by the CPs, although
some are typically genes expressed by mesenchymal cells and
could also represent a contribution of genes of stromal cells.
Among these, we have identified increased gene expression of col-
lagen type X alpha 1, upon OVX and in males in comparison to
females. An opposite trend for collagen type I regulation has been
reported in the rat ventricular myocardium where significantlyhigher (303%, P < 0.01) mRNA levels occur in the female heart
compared with the male heart (Rosenkranz-Weiss et al., 1994).
Transcription of the gene encoding for tissue inhibitor of metallo-
proteinase inhibitor 1 was decreased in the CPs of OOX animals.
Other sex differences reported in the CSF composition refer to
orexin A, which is elevated in women compared to men
(90.62 ± 15.61 pg/mL vs. 85.91 ± 14.53 pg/mL) (Schmidt et al.,
2013). Oxytocin, prolactin and leptin (Altemus et al., 1999;
Markianos et al., 2010) and CD4+ T(Reg), are also higher in the
CSF of women than in men (Tejera-Alhambra et al., 2012). Notice-
ably orexin A, oxytocin and prolactin may also originate from the
CPs, as we found expression of the genes encoding these proteins
in CPs; however, only the gene encoding for prolactin was differ-
ently expressed being higher in sham females than in OVX females
or males (Table 10). These observations suggest that the CPs may
also contribute to the homoeostasis of food intake.
4.2. The blood-CSF barrier
The junctional complexes in CPs are composed by intercellular
tight junctions between cells, which are the most apical compo-
nent of the epithelial junctional complex, adherens junctions and
desmosomes (Fig. 2). Tight junctions regulate the diffusion of
water, ions, and other small molecules through the paracellular
space between neighbouring cells, and ensure cell polarity by pre-
cluding the movement of components of the apical membrane to
the basolateral membrane. Tight junctions are composed by occlu-
din, claudins (i.e. claudin 1, 2, 3 and 11), and junctional adhesion
molecules A and C. These proteins bind the scaffolding proteins
zonula occludens 1, 2 and probably zonula occludens 3, connecting
neighbouring cells to each other’s actin cytoskeleton and recruit
cytosolic molecules which are involved in cell signalling. Of all
transmembrane proteins in tight junctions, claudins and particu-
larly claudin 1, determine the selective size, charge, and conduc-
tance properties of the paracellular pathway. Adherens junctions
are formed by the homophilic interaction of cis homodimers of
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p120- and b-catenin family that through binding to a-catenin, link
E-cadherin to the epithelial actin cytoskeleton (Schneeberger and
Lynch, 2004; Tietz and Engelhardt, 2015; Van Itallie and
Anderson, 2006).
The expression of adherens and tight junction proteins in the
blood-CSF barrier (BCSFB) has been extensively studied. Adherens
junction proteins, cadherins and catenins were identified in the
epithelial cells of CPs and in CPEC primary cultures. Kratzer et al.,
2012 analysed the expression of 14 members of the claudin family
in CPs. Of all tested, claudins 1, -2, and -3 showed the highest levelsTable 7
Genes expressed in the choroid plexuses associated with chemical surveillance.
Gene 
symbol Gene name 
F
s
Taste signalling 
Gnat3 Guanine nucleotide binding protein, alpha transducing 3  
Gnb3 Guanine nucleotide binding protein, beta polypeptide 3 
Itpr3 Inositol 1,4,5-triphosphate receptor, type 3 
Plcb2 Phospholipase C, beta 2 
Scnn1g Sodium channel, nonvoltage-gated 1 gamma 
Trpm5 Transient receptor potential cation channel, subfamily M, member 5 
Tas1r1 Taste receptor, type 1, member 1 
Tas1r3 Taste receptor, type 1, member 3 
Tas2r109 Taste receptor, type 2, member 109 
Tas2r124 Taste receptor, type 2, member 124 
Tas2r134 Taste receptor, type 2, member 134 
Tas2r137 Taste receptor, type 2, member 137 
Tas2r40 Taste receptor, type 2, member 40 
Olfactory signalling 
Ac3 Adenylate Cyclase 3 or III 
Clca4l Chloride channel calcium activated 4-like 
Clca5 Chloride channel calcium activated 5 
Cng2 Cyclic nucleotide gated channel 2 
Cnga3 Cyclic nucleotide gated channel alpha 3 
Cnga4 Cyclic nucleotide gated channel alpha 4 
Cngb1 Cyclic nucleotide gated channel beta 1 
GNAL or 
Gαolf 
Guanine Nucleotide Binding Protein (G Protein), Alpha Activating 
Activity Polypeptide, Olfactory Type 
Guca1b Guanilate cyclase activator 1B 
Pdc Phosducin 
Prkg2 Protein Kinase, cGMP-dependent, type II 
Olr19 Olfactory receptor 19 
Olr476 Olfactory receptor 476 
Olr522 Olfactory receptor 522 
Olr540 Olfactory receptor 540 
Olr611 Olfactory receptor 611 
Olr806 Olfactory receptor 806 
Olr812 Olfactory receptor 812 
Olr1105 Olfactory receptor 1105 
Olr1266 Olfactory receptor 1266 
Olr1382 Olfactory receptor 1382 
Olr1701 Olfactory receptor 1701 
OOX – orchidectyomized male rats; OVX – ovariectomized female rats 
Basal expression Fold change up-regulation 
>12 >1,5 
>8 >2 
>4  >3 
<3,99 of expression, particularly claudin 1. We found that claudins 5, -6, -
9, -10, -11, -12, -19 and -22 are also expressed in CPs (Quintela
et al., 2013) as well as occludin and zonula occludens 1. Interest-
ingly, the expression of tight junction proteins fluctuates during
the various phases of development; that of claudins 2, -9 and -22
increase along development while that of claudins 3 and -6
decrease. Therefore, an active barrier function starts early in devel-
opment as deduced from the expression of tight junction proteins
in CPs (Coisne and Engelhardt, 2011; Ek et al., 2012; Kratzer et al.,
2012, 2013; Wolburg et al., 2001) and is unlikely to be less effec-
tive at this stage. The only report on the regulation of key elementsemale 
ham 
OVX vs 
Sham 
Male 
sham 
OOX vs 
sham 
Male vs 
female 
Fold change down-regulation 
>1,5 
>2 
>3 
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DHT and E2 enhance tight junction function by decreasing paracel-
lular permeability and increasing occludin levels (Sumanasekera
et al., 2007). We found that the mRNA encoding several elements
of the junctional complexes are modulated by SH (Table 5). Claudin
1 was reduced upon OVX, and claudin 5 expression was enhanced
in males’ CPs, whilst claudin 7 expression diminished in males in
comparison to females. Claudin 12 expression diminished in the
CPs of OOX. No major differences were seen among the other cad-
herins and claudins. It is of major interest to assess if these differ-
ences in gene expression do translate into protein expression and
their impact on the paracellular transport of cells and compounds
across the BCSF between sexes.
4.3. Immune surveillance
For a long time the brain was considered isolated from the
immune system. The assumption of an immune-privileged system
was supported by the existence of a barrier system, among other
features. While these barriers protect the brain from the fluctua-
tions of blood components that are direct triggers of neuronal func-
tion (e.g. amino acids that function as neurotransmitters), it is now
clear that they are much more than obstacles to the passage of
molecules and cells. Of relevance, these barriers are now being
considered themselves as relevant places for the dialogue between
the immune system and the brain (Fig. 2). The CPs respond to rapid
and to prolonged peripheral inflammatory stimuli (Marques et al.,
2009a, 2009b, 2009c, 2012). This response is particularly of inter-
est since it displays features not present in the basal state, such
as the ability to alter the homeostasis of iron metabolism, and
influences the composition of the CSF (Marques et al., 2009a). Also
reported is the participation of the CPs in the adaptive immunity,
which is critical for the maintenance of brain function. Under phys-
iological conditions, this activity has been associated with CD4+ T
cells specific for brain self-antigens. It has been proposed that CNS-
specific T cells shape brain function via the CPs, and apparently this
immunological control may be lost with aging, particularly with
immune senescence, with a concomitant compromise of brain
function (Baruch et al., 2013; Baruch and Schwartz, 2013).
In aging and in Alzheimer’s disease mouse models, a type I
interferon (IFN-I)-dependent gene expression profile, similar to
that found in aged human brains, was identified (Baruch et al.,
2014; Mesquita et al., 2015). This response was induced by
brain-derived signals, present in the CSF (Baruch et al., 2014).
Blocking IFN-I signalling within the aged brain partially restored
cognitive function and hippocampal neurogenesis and re-
established the IFN-II-dependent CPs’ activity that is lost in aging
(Baruch et al., 2014). Based on these data it seems that the CPs
exhibit an aging-induced IFN-I signature which has a negative
impact on cognitive function (Baruch et al., 2014; Schwartz and
Baruch, 2014). It has been hypothesized that CD4+ effector memory
T cells, within the CPs’ stroma, regulate leukocyte trafficking
through the CPs’ epithelia. Interferon-type II, together with tumour
necrosis factor-a, induces immune cell trafficking molecules
through the activation of their own receptors in CPs’ epithelial cells
(Baruch et al., 2015; Kunis et al., 2013).
Of relevance, little is known about the influence of SH concern-
ing the expression, in the CPs, of molecules known to regulate the
immune function. However, it is clear that the CPs transcriptome
immune signature also depends on the hormonal status. This is
especially true for the expression of some chemokines like chemo-
kine (C motif) ligand 1, that was increased about 2-fold upon OVX,
while chemokines (C-C motif) such as ligand 2, ligand 7, ligand 20,
and chemokine (C-X-C motif) ligand 3 were reduced to half upon
OVX. Chemokine (C-C motif) ligand 1, 3 and chemokine CC beta
receptor 1 expression were increased in males in comparison tofemales (Table 6). Sex-related differences have also been found
for chemokines in several peripheral human and rodent tissues.
Lower levels of chemokine (C motif) ligand 1, in females than
males have been reported following injury, while chemokine (C
motif) ligand 3 and 20 exhibited opposite trends (Sorge and
Totsch, 2016). Also the glycosylation dependent cell adhesion
molecule 1, a very abundant adhesion molecule in male and female
CPs, was reduced upon OVX and also in males’ CPs in comparison
to females’. Interpheron alpha-1, increased upon gonadectomy in
males, suggesting that it is down-regulated by androgens (Table 6).
Whether these chemokines were expressed by CPEC or by immune
cells in the CPs’ stroma has not been further disclosed, since collec-
tion of CPs included the connective tissue underneath and the cor-
responding proteins are typically expressed by immune cells.
Moreover, sex-related differences in the barrier junctional com-
plexes as seen for cadherins and claudins (Table 5) may also
restrain the entrance of immune cells into the CSF, so trafficking
of immune cells and pathogens across the BCSFB may differ
between males and females as a consequence, a possibility that
deserves further investigation.
Several cytokines are also synthesized in the CPs and secreted
into the CSF, with clear implications in the communication
between the immune and central nervous systems (Marques
et al., 2011). Here, they will be rather discussed in the context of
neurogenesis (see below).
4.4. Chemical surveillance
The KEGG functional pathway analysis of the CPs’ cDNA
microarray results revealed the enrichment of a variety of physio-
logical processes related to chemical senses, such as the taste and
the olfactory transduction pathways, and to the detoxification of
xenobiotics (Fig. 2).
4.4.1. Taste signalling
The functionality of the taste transduction pathway was
recently confirmed in CPs epithelial cells, given the presence of
mRNA and protein for the taste receptors type 1 member 1, 2
and 3, taste receptors type 2 member 109 and 40(144) and the
downstream signalling molecules a-gustaducin, phospholipase C
beta2, inositol 1,4,5-triphosphate and transient receptor potential
channel M5. The taste transduction pathway functionality was
assessed in CPs epithelial cells, by calcium imaging, stimulated
with the bitter compound D-salicin (Tomás et al., 2016), suggesting
that taste receptors are involved in the chemical surveillance of the
CSF and/or blood composition. Previous evidence on the regulation
of this pathway by the hormonal background showed that female
rats experience changes in taste bud morphology during pregnancy
(Yücel et al., 2002). Moreover, the response of the parabrachial
pons to bitter taste is increased in OVX rats when compared to con-
trols (Di Lorenzo and Monroe, 1990). Hence, it seems likely that
SHs affect taste and nutrient sensing both at the level of the taste
buds as well as in the CNS (Faas et al., 2010; Quintela et al., 2013).
In our CPs microarray study, decline of hormone levels in female
rats clearly induced an up-regulation of 7 genes, including several
taste receptors and phospholipase C beta2 (Table 7), which were
associated with taste transduction. Interestingly, this study identi-
fied differently expressed receptors of the taste receptor type 2
family (Tas2R109, Tas2R124, Tas2R134, Tas2R137, Tas2R40)
responsible for the detection of bitter-tasting compounds that
were up-regulated upon OVX (Chandrashekar et al., 2006), and in
the case of Tas2R40, accordingly increased in males in comparison
to females. Our comparative gene expression analysis provides the
first evidence that the expression of taste-related genes in rat CPs
is under the control of SHs (Quintela et al., 2013). Finally, the fact
that this pathway is functional in CPs suggests a role for this
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‘‘tasting” the chemical composition of the CSF.
4.4.2. Olfactory signalling
The olfactory signalling in rat CPs was first put in evidence with
our comparative gene expression analysis (Quintela et al., 2013).
Hormone decline in rat CPs revealed important effects in the olfac-
tory transduction signalling, with 102 genes up-regulated and 282
down-regulated in OVX and 42 down-regulated genes in OOX.
Among these differently expressed genes, most were olfactory
receptors (ORs) (Quintela et al., 2013) and some examples of these
ORs are represented in Table 7 (Gonçalves et al., 2016). Moreover,
as indicated in Table 7, Olr 522, Olr 1266 and Olr 1701 were up-
regulated in males CPs in comparison to females’. The expression
of these receptors was double-checked by RT-PCR. The functional-
ity of this transduction pathway in murine CPs was recently
demonstrated by electrophysiology experiments using polyamines
(molecules known to be present in the CSF) as stimuli; these trig-
gered both the cAMP and the phospholipase C-inositol 1,4,5-
triphosphate signalling pathways (Gonçalves et al., 2016). ThereTable 8
Genes expressed in the choroid plexuses associated with xenobiotic metabolism and deto
Gene 
symbol Gene name 
Phase I drug metabolizing enzymes 
Adh4 Alcohol dehydrogenase 4 (class II), pi polypeptide 
Aldh1a7 Aldehyde dehydrogenase family 1, subfamily A7 
Cyp2a2 Cytochrome P450, family 2, subfamily a, polypeptide 2 
Cyp11b3 Cytochrome P450, family 11, subfamily b, polypeptide 3 
Ephx1 Epoxide hydrolase 1, microsomal 
Ephx4 Epoxide hydrolase 4 
Fmo1 Flavin containing monooxygenase 1 
Fmo3 Flavin containing monooxygenase 3 
Mao-a  Monoamine oxidase A 
Phase IIdrug metabolizing enzymes 
Gstm5 Glutathione S-transferase, mu 5 
Sult5a1 Sulfotransferase family 5A, member 1 
Sult6b1 Sulfotransferase family, cytosolic, 6B, member 1 
Ugt1a6 UDP glucuronosyltransferase 1 family, polypeptide A6 
Antioxidant enzymes 
Gpx6 Glutathione peroxidase 6 
Efflux transporters  
Abca1 ATP-binding cassette, subfamily A (ABC1), member 1 
Abca2 ATP-binding cassette, subfamily A (ABC1), member 2 
Abca7 ATP-binding cassette, subfamily A (ABC1), member 7 
Abcb1a ATP-binding cassette, sub-family B (MDR/TAP), member 1a 
Abcb1b ATP-binding cassette, subfamily B (MDR/TAP), member 1b 
Abcc1 ATP-binding cassette, subfamily C (CFTR/MRP), member 1 
Abcc3 ATP-binding cassette, subfamily C (CFTR/MRP), member 3 
Slc6d1 Solute carrier organic anion transporter family, member 6d1 
Slc22a7 Solute carrier family 22, member 7 
Slc22a8 Solute carrier family 22, member 8 
Slc22a23 Solute carrier family 22, member 23 
OOX – orchidectyomized male rats; OVX – ovariectomized female rats 
Basal expression Fold change up-regulation 
>12 >1,5 
>8 >2 
>4  >3 
<3,99 is evidence that SHs elicit alterations in olfactory function in
humans (Doty and Cameron, 2009), and steroid hormones such
as androstenone and androstadienone were identified as ORs
ligands (Keller et al., 2007). Initially identified in the sensory neu-
rons of the olfactory epithelium, recent studies showed that differ-
ent tissues also express olfactory receptors, including brain (cortex
and hippocampus), gut, muscle, kidney, placenta and cornea
(Braun et al., 2007; Griffin et al., 2009; Grison et al., 2014; Otaki
et al., 2004; Pluznick et al., 2009; Quintela et al., 2015a). The grow-
ing number of traditionally non-olfactory tissues with olfactory
receptors expression strongly suggest that these receptors must
play other physiological roles and can detect also non-volatile
molecules in body fluids. Such may be the case for the CPs, as
potential sensors of the CSF chemical composition. Other interest-
ing down-regulated gene in the CPs of OVX is phosducin. Phos-
ducin is a protein highly abundant in the retinal photoreceptor
cells and in pinealocytes (Schulz, 2001), which has been suggested
to modulate cilia of olfactory neurons (Boekhoff et al., 1997). All
these results suggest that olfactory-like chemosensory signalling,
together with taste transduction, may be essential components ofxification.
Female 
sham 
OVX vs 
Sham 
Male 
sham 
OOX vs 
Sham 
Male vs 
Female 
Fold change down-regulation 
>1,5 
>2 
>3 
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the CSF composition, and to elicit responses to modulate and main-
tain brain homeostasis.
4.4.3. Clearance of xenobiotics
There is growing evidence that drug detoxification mechanisms
are present throughout the brain, with a more intense activity at
the interface between the blood and the CSF (Choudhuri et al.,
2003; Strazielle and Ghersi-Egea, 1999). The CPs are known for
their capacity to clear potentially harmful blood- and brain-born
compounds due to the action of a wide variety of protein trans-
porters, drug metabolizing enzymes and antioxidant systems
which together have impact on the clearance of xenobiotics from
the brain (Choudhuri et al., 2003; Ghersi-Egea et al., 2006).
The clearance of xenobiotics comprises three phases; the first
two involving the enzymatic conversion into more hydrophilic
metabolites that lead ultimately to the inactivation and elimina-
tion of these exogenous compounds (phase III). Studies with CPs’
extracts have shown that genes encoding for phase I (functional-
ization) and phase II (conjugation) metabolizing enzymes are
expressed in CPs, with some of these enzymes reaching the expres-
sion levels seen in the liver, the principal site of xenobiotic meta-
bolism in the body (Ghersi-Egea et al., 1994).
Phase I enzyme components present in CPs include monoamine
oxidases, epoxide hydrolases, flavin-containing monooxygenases,
NADPH-cytochrome P450 reductase and members of the cyto-
chrome P450s family. These enzymes inactivate exogenous com-
pounds, such as pesticides and carcinogenic molecules, and
increase their susceptibility for phase II metabolizing enzymes
(Strazielle et al., 2004). Phase II enzymes produce even less toxic
and more polar compounds which enable them to be readily
excreted in urine and bile. These conjugation activities are cat-
alyzed mainly by UDP-glucuronosyl transferases, sulfotransferases
and glutathione S-transferases. Finally, metabolism products are
extruded by several efflux transporters allocated in CPs, which
include mainly the ATP-binding cassette transporter families, and
the organic anion and cation transporters of the solute carrier fam-
ilies (Ek et al., 2010; Ghersi-Egea et al., 2006). In addition to these
detoxifying systems, the CPs displays a high expression of antiox-
idant enzymes that inactivate the reactive and potentially deleteri-
ous molecules that can be formed as a result of phase I oxidative
and reductive metabolism and of phase II reactions. These include
superoxide dismutases, catalase and glutathione peroxidases
(Kratzer et al., 2013). Previous studies in the choroidal epithelium
have shown the presence of all three classes of enzymes, displaying
higher activities when compared to other brain structures (Ghersi-
Egea et al., 1994; Philbert et al., 1995).
In our CPs’ microarray study, the genes coding for phase I (e.g.
alcohol dehydrogenase 4, class II, pi polypeptide; aldehyde dehy-
drogenase family 1, subfamily a7; epoxide hydrolase 1, microso-
mal; monoamine oxidase A; flavin containing monooxygenase 3),
phase II (e.g. UDP glucuronosyltransferase 1 family, polypeptide
A6; glutathione s-transferase, mu 5) and phase III (e.g. ATP-
binding cassette, subfamily C, CFTR/MRP, member 1; solute carrier
family 22, member 23) metabolizing enzymes as well as for antiox-
idant enzymes (e.g. Gpx6) were found, which is in accordance with
previous findings (Kratzer et al., 2013; Martínez et al., 2001;
Strazielle et al., 2004).
Although the role of CPs in xenobiotics clearance has gained sig-
nificance over the last decades, there are still some issues to be
explored. For instance, researchers found some differences
between primates and rodents regarding expression of the cyto-
chromes P450 enzymes that should be taken into consideration
when translating data to the human scenario (Ek et al., 2015).
Recent studies also investigated the presence of an effective
barrier mechanism during gestation and postnatal period, demon-strating that some mechanisms are probably more relevant during
early stages of development, as their expression is higher in the
embryo than in the adult. The observed profiles suggest that the
CPs detoxification pathways appear to be efficient in the develop-
ing brain, putting in evidence a possible age dependent expression
of such enzymatic systems (Ek et al., 2015; Kratzer et al., 2013;
Richard et al., 2001).
Of notice, in the context of the present review, is the sex influ-
ence in the response to xenobiotics, since these may underlie some
of the sex-differences observed in response to pharmacological
treatments (Soldin et al., 2011; Soldin and Mattison, 2009).
Sex-dependent differences have been demonstrated for several
cytochromes P450 isozymes as well as for sulfotransferases, glu-
tathione S-transferases, and glucuronyltransferases, in rodents
(rats and mice) and in humans (Mugford and Kedderis, 1998;
Yang et al., 2012). The best examples of sex differences in xenobi-
otic metabolism come from the rat in which adult male liver
metabolize many compounds at higher rates than females
(Mugford and Kedderis, 1998) what is also influenced by age
(Dhir et al., 2006). In mice, on the contrary, female liver has the
higher metabolic capacity, but the differences are not as great as
those seen in rats (Clodfelter et al., 2006). In other species, includ-
ing humans, sex differences in xenobiotic metabolism in the liver
are less pronounced.
No studies have to date reported sex- or hormonal-related dif-
ferences in such enzymatic systems in the CPs. However, while
comparing gene expression in the CPs of female and male rats
we detected sex differences in the expression of genes associated
with cytochrome P450 mediated metabolism (Table 8). These
results are in accordance with previous studies showing a sexual
dimorphism of these enzymes in the rat and human liver (Zanger
and Schwab, 2013). The expression levels of some enzymes (e.g.
cytochrome P450, family 2, subfamily a, polypeptide 2 (Cyp2a2)
and cytochrome P450, family 11, subfamily b, polypeptide 3
(Cyp11b3)) was increased upon castration in the CPs of female rats,
suggesting a down regulation of gene expression by estrogens. In
addition, Cyp2a2 was increased in males in comparison to females
and Cyp11b3 and sulfotransferase family 5A, member were also
augmented in OOX males (Table 8).
Antioxidant enzymes activities in the brain are also of particular
interest, considering that these enzymes control reactive oxygen
species levels, which in turn can affect the permeability of the
brain barriers (Armstead et al., 1992).
Finally, we also found up-regulation of ATP-binding cassette
transporter ABCC1 in male rat CPs compared to females, while
UDP glucoronosyltransferase 1 A6 was down-regulation in males
compared to females and glutathione peroxidase 6 was up-
regulated in males vs. females (Table 8) (Quintela et al., 2013).
Taken together, these findings suggest that SHs contribute to the
transcriptional regulation of enzymes that are directly involved
in the metabolism of xenobiotics and to the efflux transporters that
participate in neuroprotective and detoxifying functions of the CPs.
Sex differences in xenobiotic metabolism may lead to major dif-
ferences in susceptibility to the toxicity of a xenobiotic. For exam-
ple, several studies have demonstrated differences in vulnerability
to the neurotoxic effects of alcohol and methamphetamines
between males and females (Alfonso-Loeches et al., 2013;
Bourque et al., 2011). It is, therefore, essential to understand the
sex differences in xenobiotic metabolism and in drug metabolism
and disposal, as they may affect drug safety and effectiveness. This
is particularly important in brain barriers regarding drugs targeting
brain diseases and brain metastasis.
4.4.4. Clearance of amyloid beta
Brain accumulation of amyloid b is an important hallmark of
neurodegeneration in Alzheimer’s disease, which may be a conse-
Table 9
Genes expressed in the choroid plexus associated with amyloid beta synthesis and metabolism.
Gene 
symbol Gene name 
Sham 
Female 
OVX vs 
Sham 
Male 
Sham 
OOX vs 
Sham 
Male vs 
Female 
App Amyloid beta precursor protein 
Bace1 Beta-site APP-cleaving enzyme 1 
Bace2 Beta-site APP-cleaving enzyme 2 
Psen1 Presenilin 1 
Psen2 Presenilin 2 
Ncstn Nicastrin 
Ager Advanced glycosylation end product-specific receptor (RAGE) 
Lrp1 Low density lipoprotein-related protein 1 
Lrp2 Low density lipoprotein-related protein 2/Megalin 
Clu Clusterin/Apolipoprotein J 
Ttr Transthyretin 
Gls Gelsolin 
Ide Insulin degrading enzyme 
Nep Neprilysin 
Ece1 Endothelin converting enzyme 1 
Ece2 Endothelin converting enzyme 2 
Mt1 Metallothionein 1 
Mt2 Metallothionein 2 
Mt3 Metallothionein 3 
OOX – orchidectyomized male rats; OVX – ovariectomized female rats 
Basal expression Fold change up-regulation Fold change down-regulation 
>12 >1,5 >1,5 
>8 >2 >2 
>4  >3 >3 
<3,99 
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metabolism and clearance (Kepp, 2016). The CPs are an active site
of amyloid b clearance whose function becomes compromised in
aging and in Alzheimer’s disease mouse models with reduced
production of CSF, diminished secretion of transthyretin, an
amyloid-beta scavenger, and alterations in several transporters
involved in the extrusion of amyloid beta from the CNS (Alvira-
Botero and Carro, 2010; González-Marrero et al., 2015;
Matsumoto et al., 2015; Pascale et al., 2011). Besides, the CPs also
express other relevant genes for the production of amyloid beta
such as the amyloid beta precursor protein, beta-site APP-
cleaving enzyme 1 and 2, presenilin 1 and 2 and nicastrin (Table 9).
Many of these molecules involved in brain amyloid b surveillance
(from amyloid b production to clearance) are regulated by SH
within the CNS and in peripheral tissues giving support to the
argument that SH decline during aging may contribute to Alzhei-
mer’s disease onset and progression (Duarte et al., 2016). However,
despite the high expression of genes involved in amyloid b produc-
tion in CPs, such as amyloid b precursor protein, and nicastrin, no
major alterations were observed between males and females or as
a result of gonadectomy (Table 9). The uptake of amyloid b peptide
is mediated by specific transport mechanisms in the BCSFB, which
include ABC transporters, receptor for advanced glycation end
products, low-density lipoprotein receptor related protein 1,
megalin/low-density lipoprotein receptor related protein 2/glyco-
protein 330, and apolipoprotein J/clusterin. The regulation of ABC
transporters by SH in the CPs has already been discussed in the
section above.
Other proteins that may be involved in amyloid b degradation
are metallothioneins either by interaction with transthyretin or
by their anti-inflammatory and anti-oxidant properties (Santoset al., 2012). Most of these genes associated with amyloid
b degradation, metabolism and clearance presented little
differences in its levels of expression between sexes (below 50%),
which are not indicated in Table 9. The gene encoding the enzyme
neprilysin, however, decreased almost 90% in castrated females
and was down-regulated in males in comparison to females,
suggesting an up-regulation by ovarian hormones.
4.5. Neurogenesis
The differences in neurogenesis in the dentate gyrus of the hip-
pocampus between sexes, as well as its regulation by the SH back-
ground have been under the scope of recent reviews (Galea et al.,
2013; Mahmoud et al., 2016; Pawluski et al., 2009). These put in
evidence that androgens increase survival of new neurons in the
hippocampus of young adult males, while estrogens increase pro-
liferation of new cells in the hippocampus of young adult females
depending on the reproductive history and timing (eg. estrous
cycle, reproduction, stress, and aging). Neurogenesis at the subven-
tricular zone is also susceptible to the effects of SH (Farinetti et al.,
2015; Tatar et al., 2013; Zheng et al., 2013) which determine cell
survival and proliferation. It is likely that some of these differences
result from the combined action of neurogenic factors regulated by
SH in the abut CPs.
The most expressed mRNA in CPs encoding peptides with doc-
umented involvement in neurogenesis are indicated in Table 10.
Data from rat and mouse CPs’ cDNA microarrays (Falcao et al.,
2012; Marques et al., 2011; Quintela et al., 2013) are in concert
in what regards the relative abundance of these peptides. Herein
we highlight differences in the relative expression of the mRNA
encoding these peptides according to the SH background.
Table 10
Genes expressed in the choroid plexuses associated with neurogenesis.
Gene 
symbol Gene name 
Female 
sham 
OVX vs 
Sham 
Male 
sham 
OOX vs 
Sham 
Male vs 
Female 
Growth factors
Igf1 Insulin-like growth factor 1 
Igf2 Insulin-like growth factor 2 
Igf2bp1 Insulin-like growth factor 2 mRNA binding protein 1 
Igf2bp2 Insulin-like growth factor 2 mRNA binding protein 2 
Tgfa Transforming growth factor alpha 
Cytokines and chemochines 
Il1a Interleukin 1 alpha 
Il1b Interleukin 1 beta 
Il7 Interleukin 7 
Il9 Interleukin 9 
Il11 Interleukin 11 
Il15 Interleukin 15 
Il17c Interleukin 17C 
Gh Growth hormone 
Ghr Growth hormone receptor 
Prl Prolactin 
Wnt/ frizzled pathway
Frzb Frizzled-related protein 
Fzd1 Frizzled homolog 1 (Drosophila) 
Fzd2 Frizzled homolog 2 (Drosophila) 
Fzd3 Frizzled homolog 3 (Drosophila) 
Fzd6 Frizzled homolog 6 (Drosophila) 
Fzd7 Frizzled homolog 7 (Drosophila) 
Fzd8 Frizzled homolog 8 (Drosophila) 
Sfrp2 Secreted frizzled-related protein 2 
Wnt1 Wingless-type MMTV integration site family, member 1 
Wnt4 Wingless-type MMTV integration site family, member 4 
Wnt5a Wingless-type MMTV integration site family, member 5a 
Wnt5b Wingless-type MMTV integration site family, member 5b 
Cell diferentiation and neuroprotection 
Dbh Dopamine beta-hydroxylase 
Gata4 GATA binding protein 4 
Gfra1 GDNF family receptor alpha 1 
Hoxa2 Homeo box A2 
Retinoate biosynthesis 
Rbp1 Retinol binding protein 1, cellular 
Rdh5 Retinol dehydrogenase 5 
Rdh10 retinol dehydrogenase 10 (all-trans) 
HIPPO signalling 
Inadl2 InaD-like 2 (Drosophila) 
Ppm1j Protein phosphatase 1J 
Sfn Similar to 14-3-3 protein sigma 
OOX – orchidectyomized male rats; OVX – ovariectomized female rats 
Basal expression Fold change up-regulation Fold change down-regulation 
>12 >1,5 >1,5 
>8 >2 >2 
>4  >3 >3 
<3,99 
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growth factors, platelet derived growth factors, epidermal growth
factor, and brain derived growth factor with a role on neurogenesis
are all expressed in CPs (Marques et al., 2011). While the most
abundant fibroblast growth factor family members (e.g. FGF-2,
FGF-8 and FGF-10, epidermal growth factor and platelet derivedgrowth factors alpha) did not show relevant differences between
different SH backgrounds, other strong inducers of neurogenesis
in vitro (Pastrana, 2013) seem to be sensitive to hormonal varia-
tions. Transforming growth factor alpha mRNA was reduced upon
OVX and concurrently, also reduced in males in comparison to
females’ CPs. Previous studies report that in the mice hypothalamus
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males than females like in the CPs (Koshibu and Levitt, 2005).
The CPs express both insulin-like growth factors 1 and 2 and
growth hormone receptor transcripts (Falcao et al., 2012;
Marques et al., 2011; Quintela et al., 2013); which suggests the
possibility of autocrine regulation. Both have proliferative actions
in the developing cortical ventricular zone surface, and in the adult
subventricular zone (Iwamoto and Ouchi, 2014; Nieto-Estévez
et al., 2016; O’Kusky and Ye, 2012; Ziegler et al., 2015). Insulin-
like growth factor 1, but not 2, is sensitive to the SH background,
decreasing about 1.6-fold upon OVX. Interestingly the binding pro-
tein of IGF2 binding protein-like 1 (Igf2bpl1) is nearly 4-fold
increased in the male’s CPs compared to female’s (Table 10).
Cytokines are an interesting group of modulators of neurogen-
esis synthesized in the CPs’ stroma and epithelia (Schwerk et al.,
2015). These include several interleukins such as IL-1a, IL-1b, IL-
5, IL-6, IL-7, IL-8, IL-9 and IL-15 (Borsini et al., 2015; Gómez-
Nicola et al., 2011; Larsen and Grattan, 2012; Mehler et al., 1993;
Michaelson et al., 1996; Nyberg and Hallberg, 2013; Rozental
et al., 1995). IL-1b, IL-9, IL-11 and IL-15 transcripts are particularly
abundant species in CPs. While IL-1b was significantly up-
regulated in males in comparison to females, the other interleukins
did not show any significant expression differences according to
the SH background. Other less abundant interleukins, on the other
hand, seem to be modulated by SH. IL-1a and IL-17C are up-
regulated in the CPs of OVX compared to controls, and IL17C is also
up-regulated in males vs females. However, IL-7 and IL-9 expres-
sion were both reduced in the CPs of adult rats following OVX,
and also in sham males in comparison to females. IL-1a, is known
to regulate neurogenesis in rat fetal mesenphalic neural precursor
cells. IL-7 and IL-9 have been associated with differentiation of hip-
pocampal neuroblasts into neurons during development and with
increased neuronal survival (Mehler et al., 1993; Michaelson
et al., 1996; Rozental et al., 1995). IL-17C an isoform of ILC-17A,
enhances neurite outgrowth, and may have a role in the neuronal
plasticity associated with inflammation (Chisholm et al., 2012).
Based on microarray data (Marques et al., 2011; Quintela et al.,
2013) the CPs also express two transcripts encoding two classical
pituitary hormones with relevant roles in neurogenesis; growth
hormone and prolactin (Aberg, 2010; Larsen and Grattan, 2012).
Both hormones induce neuronal progenitor proliferation, and pro-
mote neural stem cell migration, but only prolactin has prolifera-
tive effects on glial progenitors (Pathipati et al., 2011). Prolactin
induces neurogenesis in the subventricular zone during pregnancy
and is responsible for the establishment of maternal behavior
(Larsen and Grattan, 2010; Pathipati et al., 2011; Shingo et al.,
2003). Besides, it also stimulates neurogenesis at the hippocampus
and impairs stress and anxiety behaviors after pregnancy (Torner
et al., 2009; Walker et al., 2012). Gene expression of growth hor-
mone or prolactin in the CPs has not been described so far, in spite
of the presence of the proteins in the CPs’ epithelia and in the CSF
(Table 3). Up to recently this was thought to be a result of receptor
mediated uptake of these hormones by their cognate receptors
which are highly expressed at the CPs’ epithelia. Recent findings
suggest that other possible sources of prolactin may exist in the
CSF, as receptor mediated uptake alone is unlikely to justify pro-
lactin levels in the CSF (Brown et al., 2016). Based on the basal
levels of expression of prolactin and growth hormone in the rat
female CPs and in mouse CPs (Marques et al., 2011), the CPs may
be a likely source of both hormones. Ovariectomy reduced pro-
lactin expression, and prolactin transcripts are more abundant in
the female’ CPs than in males’ what resembles the well-known
up-regulatory effect of oestrogen’s over PRL expression seen in
the pituitary gland (Freeman et al., 2000).
The Wingless/frizzled pathway was associated with the forma-
tion, maintenance, proliferation and migration of adult neural stemcells (Malaterre et al., 2007) and is represented in the adult CPs of
rats by wingless-type MMTV integration site family, member 1, 4,
5a and b, 7 and 9 and frizzled homolog 1, 2, 3, 6, 7, 8, and by
frizzled-related protein and secreted frizzled-related protein.
Wingless-type MMTV integration site family, member 4 expression
increases following male gonadectomy, and wingless-type 4 and
secreted frizzled-related protein are down-regulated in males
compared to females’ CPs.
Other genes associated with embryonic cell differentiation,
dopamine beta-hydroxilase, GATA binding protein 4, glial-derived
neurotrophic factor receptor alpha 1 and Homeo box A2, are
known to regulate human embryonic stem cell renewal and differ-
entiation and vascular remodelling (Fessner et al., 2014) and are
down-regulated in males compared to females. Also, the genes
associated with the visual cycle/retinoate biosynthesis retinol
binding protein 1 and retinol dehydrogenase are seminal elements
of the retinoic acid metabolism which is also fundamental for stem
cell differentiation and frequently used to promote neural differen-
tiation of pluripotent cells into neural cells (Okada et al., 2004). The
down-regulation of retinol dehydrogenase 5 and 10 in male rat CPs
compared to females’ suggest that SHs may modulate the produc-
tion of retinaldehyde from retinol in CPs (Yamamoto et al., 1996),
which may be necessary for the development of the CNS. Retinol
binding protein 1 is also decreased upon OVX and in males
compared to females which may affect the transport of
CPs-borne retinoic acid to the neurogenic niches of the brain.
In addition, the HIPPO signalling pathway that plays a key role
in tissue homeostasis and organ size control by regulating tissue-
specific stem cells, tissue repair and regeneration (Mo et al.,
2014) is also downregulated in males vs females as shown by the
diminished expression of InaD-Like2 (Drosophila), protein phos-
phatase 1J and stratifin (Table 10).
Altogether, several sex differences are present in homeostatic
mechanisms that may be of relevance for development and/or
tissue regeneration. It is important to further evaluate whether
these changes in gene expression do result in alterations in the
protein levels to a point that influence specific metabolic processes
and justify sex differences in physiological and/or pathological
conditions.4.6. The CPs as a circadian oscillator
Most physiological processes in mammals are influenced by cir-
cadian rhythms. These rhythms, have an endogenous periodicity of
approximately 24 h and are driven by a master clock within the
hypothalamic suprachiasmatic nuclei that synchronizes numerous
subsidiary oscillators in extra-suprachiasmatic nuclei and periph-
eral tissues (Reppert and Weaver, 2001; Yamamoto et al., 2004).
The suprachiasmatic nuclei is not the only structure in the brain
displaying daily oscillations. Olfactory bulb, amygdala, lateral
habenula, cerebellum, a variety of nuclei in the thalamus and
hypothalamus, and the CPs (Fig. 2), contain the molecular machin-
ery necessary for the generation of circadian rhythms (Albrecht,
2012; Guilding and Piggins, 2007; Quintela et al., 2015b). At the
molecular level, circadian rhythms in central and in peripheral
oscillators are cell-autonomous and widely described as a network
of interlocking transcriptional/translational feedback loops involv-
ing a family of clock genes and their protein products (Ko and
Takahashi, 2006). At the core of this clock network are the tran-
scriptional activators, circadian locomoter output cycles protein
kaput (CLOCK) and brain and muscle Arnt-like protein (BMAL; iso-
forms 1 and 2), associated as heterodimers, that bind to enhancer
box sequences in the promoters of period 1 and period 2 (Per1
and Per2) and cryptochrome 1 and cryptochrome 2 (Cry1 and
Cry2) genes, whose proteins, in turn, form multimeric complexes
Table 11
Genes expressed in the choroid plexuses associated with circadian rhythm.
Gene 
symbol Gene name 
Female 
sham 
OVX vs 
Sham 
Male 
sham 
OOX vs 
Sham 
Male vs 
Female 
Arntl Aryl hydrocarbon receptor nuclear translocator-like 
Ciart Circadian associated repressor of transcription 
Clock Clock 
Cry1 Cryptochrome 1 
Cry2 Cryptochrome 2 
Dbp D site of albumin promoter (albumin D-box) binding protein 
Per1 Period homolog 1 (Drosophila) 
Per2 Period homolog 2 (Drosophila) 
Per3 Period homolog 3 (Drosophila) 
OOX – orchidectyomized male rats; OVX – ovariectomized female rats 
Basal expression Fold change up-regulation Fold change down-regulation 
>12 >1,5 >1,5 
>8 >2 >2 
>4  >3 >3 
<3,99 
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inhibiting their own transcription (Ko and Takahashi, 2006).
The most robust rhythms, beyond those observed in the
suprachiasmatic nuclei, are found in the olfactory bulb and tissues
that have neuroendocrine functions, such as the arcuate nucleus,
the paraventricular nucleus and the pituitary gland (Albrecht,
2012). In addition, several studies demonstrated a number of dif-
ferences that exist between brain tissues, including the robustness
and phase of the oscillations (Abe et al., 2002). The absence or
attenuated oscillations in some brain regions may allow for strong
phase control by the suprachiasmatic nuclei. On the other hand,
more robust oscillations may provide increased liability and a
wider range of phase relationships between the suprachiasmatic
nuclei and the target tissue. The suprachiasmatic nuclei is thus
believed to communicate with its targets in the brain via a combi-
nation of neuronal and humoral mechanisms (Urlep and Rozman,
2013). However, it is not known if the CPs interact with the
suprachiasmatic nuclei or even if the choroidal clock is under the
influence of the brain’s biological clock located in the suprachias-
matic nuclei. Thus, there is a clear need for further research to
understand the degree of CP’s autonomy and possible signals/cir-
cuits from the suprachiasmatic nuclei that could synchronize the
CPs, or vice versa, since the circuits are critical for regulating phys-
iology and behavior (Albrecht, 2012).
We have recently shown that the CPs expresses all canonical
clock genes Bmal1, Clock, Cry1, Cry2, Per1 and Per2 as well as their
cognate proteins (Quintela et al., 2015a). Interestingly, the expres-
sion of some of the clock genes in rat CPs exhibited circadian vari-
ations that differ between sexes. Bmal1, Cry2, Per1 and Per2 are
rhythmically expressed in female rat CPs. In addition, Cry2 and
Per2 also varied along the day in CPs of male rats. In contrast,
Bmal1 and Per1 do not show a significant circadian variation in
male rat CPs and Clock was found to be constitutively expressed
in the CPs of both female and male rats (Quintela et al., 2015b).
Thus, the expression of canonical clock genes put the CPs forward
as a likely extra-suprachiasmatic nuclei clock. However, the func-
tional significance of this clock machinery is still unknown.
Data retrieved from the microarray study documented the dif-
ferential expression of some clock genes between males and
females (Quintela et al., 2016) and as a result of gonadectomy in
both sexes. For example, Bmal 1 is down-regulated, while others
are up-regulated in the CPs of males compared to the CPs offemales (Per2 and Per3) (Table 11). Comparison of gene expression
levels between gonadectomized and sham animals showed Per2
up-regulation and Bmal1 down-regulation in OVX. Contrarily, in
OOX Per2 was down-regulated (2.5-fold) and Bmal1 up-regulated
(Table 11).
Circadian associated repressor of transcription (Ciart) also
known as Chrono (Anafi et al., 2014) represses the transcriptional
activator activity of the CLOCK/BMAL heterodimer. This is another
recently identified key element of the circadian oscillator, that is
also expressed by the CPs’ cells and alike Per 2, and Per 3 is up-
regulated in males in comparison to females (Ciart, 8.4-fold). In
addition, D site of albumin promoter (albumin D-box) binding
protein (Dbp) is also a transcriptional activator that modulates
important clock output genes (Yamaguchi et al., 2000). Dbp is
increased in OVX and in males in comparison to females, whilst
it is down-regulated in OOX. The differential expression of funda-
mental genes responsible for setting the circadian rhythmicity
between males and females suggest that SHs are key regulators
of the CPs rhythmicity. It is therefore clear that sex hormones reg-
ulate not only genes in the suprachiasmatic nuclei (reviewed in
Mong et al., 2011)(Nakamura et al., 2005, 2010) but also in the
CPs. Taken together, these observations suggest that the CPs may
act as an extra-suprachiasmatic nuclei site of estrogen action,
possibly functioning as an indirect route that can then modulate
circadian rhythmicity. Future studies addressing the circadian
clock-coordinated detoxification system of the CPs will be relevant
for understanding the pharmacokinetics of drugs along the day,
and improve drug efficacy and safety via the coordination of time
of medication with the biological rhythms.5. Conclusions
High throughput techniques such as cDNAmicroarrays and RNA
sequencing have unveiled the transcriptome of the CPs in several
experimental setups, from the early mammalian developmental
stages until adulthood, in response to inflammatory stimulus,
throughout aging, SH decline and between sexes. The available
data reinforces the importance of the CPs in CSF production,
immune surveillance, neurogenesis and brain repair, and brain
detoxification metabolism. Other novel CPs functions, including
chemical sensing through the olfactory and taste transductions
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confirmed by physiological experiments. The relevance of the CPs
in the establishment of circadian rhythms and its contribution to
neurogenesis has also received paramount support from these
studies.
The large number of CPs’ genes essential to its biological func-
tions, that are differently expressed between sexes and by the SH
background, bring forward the relevance of SH for all known CPs
functions, with particular emphasis for neurogenesis and circadian
rhythm pathways (Fig. 2). It is of major interest to assess if these
differences in gene expression do translate into protein expression
and modulate functional outcomes between sexes, as expected
from these data. Since the CPs used in these studies included the
connective tissue underneath, it is also important to deploy studies
that enable distinguishing between the source of many of these
transcripts and encoded peptides; whether these are expressed
and released frommesenchymal cells within the CP stroma or from
the CPs’ epithelial cells. Moreover, considering that some of the
gene expression differences may arise from mesenchymal cells,
another question arising from these observations is how sex
hormone-driven alterations in the expression of these genes affect
the cross-talk between the CPs’ stroma and the CPs’ epithelial cells.
Functional differences between male and female CPs are
expected to impact on health and disease and may explain some
of the differences seen in the onset and progression of neuronal
diseases between sexes.Acknowledgements
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